The Alzheimer’s Association Welcomes a New Era of Treatment
On July 6, the U.S. Food and Drug Administration granted traditional approval of Leqembi for the treatment of early Alzheimer’s disease, signifying a new era of treatment for individuals diagnosed with the disease. “This is the first traditional approval of an Alzheimer’s treatment that changes the underlying course of the disease by slowing its progression,” … Read more